Valuation: Southern Acids (M)

Market Cap 412M 102M 87.69M 82.5M 74.98M 141M 9.73B 143M 968M 379M 4.87B 381M 373M 16.21B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -14.29M -3.52M -3.04M -2.86M -2.6M -4.89M -337M -4.96M -33.56M -13.15M -169M -13.22M -12.93M -562M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
1 day+0.33%
1 week-0.66%
Current month-1.95%
1 month-1.63%
3 months-5.94%
6 months-12.75%
Current year-5.35%
1 week 3
Extreme 3
3.12
1 month 3
Extreme 3
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 15/07/2015
Director of Finance/CFO 58 01/10/2013
Chief Tech/Sci/R&D Officer 38 16/07/2014
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 79 15/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-0.66%-11.73%-13.75% 101M
-0.51%-1.27%+28.38%+387.86% 5.87B
+2.99%+4.19%+33.68%+105.88% 1.78B
+5.88%-2.70%+16.55%+89.47% 877M
-7.87%+0.19%+29.37%+15.87% 643M
-8.45%+9.14%-9.58%-19.64% 607M
-0.73%-1.16%+45.40%+105.14% 585M
+4.02%+28.96%+91.93%+29.77% 500M
+1.33%+6.93%+10.75%+13.31% 398M
+1.80%-3.56%+21.18%+68.28% 293M
Average -0.12%+4.03%+25.59%+78.22% 1.17B
Weighted average by Cap. -0.00%+2.27%+28.83%+226.73%

Financials

2025 2026
Net sales 1.11B 272M 235M 221M 201M 378M 26.1B 384M 2.6B 1.02B 13.05B 1.02B 1B 43.48B 934M 230M 199M 187M 170M 319M 22.03B 324M 2.19B 859M 11.02B 863M 845M 36.7B
Net income 36.7M 9.04M 7.81M 7.35M 6.68M 12.56M 866M 12.74M 86.18M 33.77M 433M 33.94M 33.21M 1.44B 37.38M 9.21M 7.95M 7.48M 6.8M 12.79M 882M 12.98M 87.76M 34.39M 441M 34.57M 33.82M 1.47B
Net Debt -367M -90.37M -78.05M -73.44M -66.74M -126M -8.66B -127M -861M -338M -4.33B -339M -332M -14.42B -426M -105M -90.73M -85.36M -77.58M -146M -10.06B -148M -1B -392M -5.03B -394M -386M -16.77B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
19/08/26 MYR 3.010 +0.33% 31,100
18/08/26 MYR 3.000 -0.33% 16,300
17/08/26 MYR 3.010 0.00% 18,100
14/08/26 MYR 3.010 0.00% 28,100
13/08/26 MYR 3.010 -0.33% 68,700
  1. Stock Market
  2. Stocks
  3. 5134 Stock